Bausch Health Companies Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bausch Health Companies Inc with three other pharmaceutical manufacturers in North America: Vertex Pharmaceuticals Inc of UNITED STATES (2020 sales of $6.21 billion of which 62% was TRIKAFTA), Zoetis Inc of UNITED STATES ($6.68 billion of which 53% was US), and Regeneron Pharmaceuticals Incorporated which is also based in UNITED STATES ($8.50 billion of which 58% was EYLEA).

Sales Analysis. During the year ended December of 2020, sales at Bausch Health Companies Inc were C$10.75 billion (US$8.52 billion). This is a decrease of 5.5% versus 2019, when the company's sales were C$11.38 billion. Contributing to the drop in overall sales was the 7.8% decline in U.S. Diversified Products Segment, from C$1.69 billion to C$1.56 billion. There were also decreases in sales in Bausch + Lomb / International Segment (down 5.9% to C$5.90 billion) and Salix (down 4.7% to C$2.55 billion) and Ortho Dermatologics (down 0.9% to C$740.58 million) .